Study S000163

Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity

Included trial: extracted data ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)Informed Consent Form (PDF)

Registration

Registration: NCT03523273
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: COMPLETED
Enrollment: 136
Start: 2017-11-29
Primary completion: 2021-08-31
Lead sponsor: Michael Camilleri, MD
Conditions: Obesity
Interventions: DRUG:Liraglutide; DRUG:Placebo
Results posted: TRUE
Secondary identifiers: NIH:R56DK067071; NIH:UL1TR000135

Registered primary outcomes

Gastric Emptying of Solids (T1/2) [5 weeks]
Gastric Emptying of Solids (T1/2) [16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.